Doximity EBITDA 2020-2025 | DOCS
Doximity annual and quarterly EBITDA history from 2020 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Doximity EBITDA for the quarter ending March 31, 2025 was $0.052B, a 14.99% increase year-over-year.
- Doximity EBITDA for the twelve months ending March 31, 2025 was $0.237B, a 33.19% increase year-over-year.
- Doximity 2025 annual EBITDA was $0.237B, a 33.19% increase from 2024.
- Doximity 2024 annual EBITDA was $0.178B, a 20.7% increase from 2023.
- Doximity 2023 annual EBITDA was $0.147B, a 11.03% increase from 2022.
| Doximity Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $237 |
| 2024 | $178 |
| 2023 | $147 |
| 2022 | $133 |
| 2021 | $64 |
| 2020 | $28 |
| 2019 | $12 |
| Doximity Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $52 |
| 2024-12-31 | $81 |
| 2024-09-30 | $55 |
| 2024-06-30 | $49 |
| 2024-03-31 | $45 |
| 2023-12-31 | $61 |
| 2023-09-30 | $37 |
| 2023-06-30 | $35 |
| 2023-03-31 | $38 |
| 2022-12-31 | $43 |
| 2022-09-30 | $38 |
| 2022-06-30 | $28 |
| 2022-03-31 | $33 |
| 2021-12-31 | $40 |
| 2021-09-30 | $30 |
| 2021-06-30 | $30 |
| 2021-03-31 | $16 |
| 2020-12-31 | $21 |
| 2020-09-30 | $13 |
| 2020-06-30 | $4 |
| 2020-03-31 | |
| 2019-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $10.768B | $0.570B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.976B | 58.49 |
| Hims & Hers Health (HIMS) | United States | $14.001B | 145.46 |
| Tempus AI (TEM) | United States | $9.502B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.300B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.719B | 58.11 |
| Hinge Health (HNGE) | United States | $3.507B | 0.00 |
| Privia Health (PRVA) | United States | $2.299B | 157.17 |
| 10x Genomics (TXG) | United States | $1.611B | 0.00 |
| Phreesia (PHR) | United States | $1.567B | 0.00 |
| Azenta (AZTA) | United States | $1.481B | 68.81 |
| Enovis (ENOV) | United States | $1.470B | 8.20 |
| Schrodinger (SDGR) | United States | $1.433B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.415B | 0.00 |
| Omnicell (OMCL) | United States | $1.394B | 26.34 |
| Evolent Health (EVH) | United States | $1.172B | 99.80 |
| Claritev (CTEV) | United States | $0.632B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.564B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.494B | 0.00 |
| Talkspace (TALK) | United States | $0.387B | 115.50 |
| Carlsmed (CARL) | $0.361B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.346B | 0.00 |
| TruBridge (TBRG) | United States | $0.309B | 684.67 |
| Outset Medical (OM) | United States | $0.267B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.249B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.245B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.188B | 0.00 |
| CapsoVision (CV) | United States | $0.181B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.118B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.076B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |